Latest Advances in the Treatment of Sinus and Nasal Diseases

Dear Colleagues,

There have been significant advances in the management of sinus and nasal diseases, from understanding the pathophysiology and diagnosis of chronic rhinosinusitis to the development of new techniques and technologies with the expansion of endoscopic sinus surgery to areas beyond the paranasal sinuses.

Diseases of the paranasal sinuses extends to adjacent areas such as the orbit and skull base, affecting the patient’s quality of life. Furthermore, chronic rhinosinusitis remains a heterogenous and complex disease with emerging research on the microbiome, innate immunity and the role of new therapies, such as immunotherapy.

Endoscopic sinus surgery has also improved outcomes for patient with chronic rhinosinusitis. However, controversy remains about the extent of sinus surgery and its benefits on the quality of life of patients. The expanded endonasal approach has also allowed the treatment of diseases of the skull base, orbit and brain.

Therefore, the purpose of this Special Issue is to review current advancements and controversies in the treatment of patients with sinus and nasal diseases with a focus on chronic rhinosinusitis, its effects on patient’s quality of life and the expanded endoscopic surgical approaches to pathology beyond the paranasal sinuses.

Prof. Dr. Eng Ooi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.